Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04292743
Title Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Georgetown University
Indications

pancreatic adenocarcinoma

Therapies

Eryaspase + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.